Search Orphan Drug Designations and Approvals
-
Generic Name: | dihydroxyphenylalanine F 18/Fluorodopa (F18) |
---|---|
Date Designated: | 01/22/2018 |
Orphan Designation: | Diagnostic for the management of congenital hyperinsulinism |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Society of Nuclear Medicine and Molecular Imaging 1850 Samuel Morse Drive Reston, Virginia 20190 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-